Search

» » » Amgen’s Gene-Targeting Drug Shrank 54% of Lung Tumors in Study - Bloomberg

Amgen’s Gene-Targeting Drug Shrank 54% of Lung Tumors in Study - Bloomberg

Amgen’s Gene-Targeting Drug Shrank 54% of Lung Tumors in Study  Bloomberg

More than half of patients with an advanced form of lung cancer initially responded to an experimental drug from Amgen Inc. that targets a genetic driver of the ...

View full coverage on Google News
Amgen’s Gene-Targeting Drug Shrank 54% of Lung Tumors in Study - Bloomberg
Read More


Bagikan Berita Ini

0 Response to "Amgen’s Gene-Targeting Drug Shrank 54% of Lung Tumors in Study - Bloomberg"

Post a Comment

Subscribe to: Post Comments (Atom)
Powered by Blogger.